Cost-effectiveness of the demands and capacities model-based treatment compared to the Lidcombe Programme of early stuttering intervention: a randomised trial (the Rotterdam Evaluation study of Stuttering Treatment in children- A Randomized Trial)

ISRCTN ISRCTN24362190
DOI https://doi.org/10.1186/ISRCTN24362190
Secondary identifying numbers N/A
Submission date
05/09/2007
Registration date
05/09/2007
Last edited
29/07/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mrs Caroline de Sonneville Koedoot
Scientific

Erasmus University
Afdeling iBMG
P.O. Box 1738
Rotterdam
3000 DR
Netherlands

Phone +31 (0)10 408 8617
Email desonneville@bmg.eur.nl

Study information

Study designMulticentre single-blinded randomised active-controlled parallel-group trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific titleCost-effectiveness of the demands and capacities model-based treatment compared to the Lidcombe Programme of early stuttering intervention: a randomised trial (the Rotterdam Evaluation study of Stuttering Treatment in children- A Randomized Trial)
Study acronymRESTART
Study objectivesThe Lidcombe Programme for early stuttering intervention is more cost-effective than the Demands and Capacities Model-based treatment.

On 10/01/2012 the overall trial end date was changed from 30/07/2010 to 01/12/2011.
Ethics approval(s)Ethics board of the Erasmus University in Rotterdam (Medisch Ethische Toetsings Commissie [METC]), 10/05/2007, ref: MEC-2006-349
Health condition(s) or problem(s) studiedStuttering pre-schoolers
InterventionDemands and Capacities Model based treatment versus Lidcombe Programme.
Intervention typeOther
Primary outcome measure1. The percentage of recovered children at 18 months post randomisation
2. The costs for a recovered child
All primary outcome measures will be measured at 3, 6, 12 and 18 months post starting the therapy.
Secondary outcome measures1. The frequency of stuttering outside the clinic at 18 months post randomisation
2. The Health Utility Index
3. Visual Analogue Scale (Euroqol VAS proxy)
4. Child Health Questionnaire
5. Children Behaviour Check List
All secondary outcome measures will be measured at 3, 6, 12 and 18 months post starting the therapy, except the Children Behavioural Check List, which will be measured at 18 months only.
Overall study start date01/08/2007
Completion date01/12/2011

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit3 Years
Upper age limit6.3 Years
SexBoth
Target number of participants196
Key inclusion criteria1. Aged 3.0 to 6.3 years
2. Frequency of stuttering at least 3%
3. Parent and one therapist agree the child stutters
4. Parent rating of stuttering severity on an 8-point scale of at least 2
5. Proficiency in Dutch for children and parents
Key exclusion criteria1. Onset of stuttering within 6 months before recruitment
2. Treatment for stuttering during the previous 12 months
3. Diagnosed language disorder
4. Neurological, emotional, cognitive, behavioural or autism spectrum disorder
Date of first enrolment01/08/2007
Date of final enrolment01/12/2011

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Erasmus University
Rotterdam
3000 DR
Netherlands

Sponsor information

Erasmus Medical Centre (The Netherlands)
Hospital/treatment centre

Department of Health Policy and Management
P.O. Box 1738
Rotterdam
3000 DR
Netherlands

Website http://www.erasmusmc.nl/content/englishindex.htm
ROR logo "ROR" https://ror.org/018906e22

Funders

Funder type

Research organisation

Netherlands Organisation for Health Research and Development
Private sector organisation / Other non-profit organizations
Alternative name(s)
Netherlands Organisation for Health Research and Development
Location
Netherlands

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 28/07/2015 Yes No